KLK3 and prostate cancer: Lan et al. achieved an LOD of 6 pM for the detection of VEGF, in breast cancer, but with a similar experiment, Farka et al. were able to lower the LOD to 42 fM for PSA, a circulating protein in prostate cancer (Figure 6d,e) [53].